Indeed, high FAM215A expression was significantly correlated with tumor size, vascular invasion, and pathology stage in HCC, and FAM215A upregulation was also closely correlated with the recurrence-free survival of HCC patients (Figure 1B,C). Here, FAM215A is linked to hepatocellular carcinoma.